Cheers paleje, reads well.
There must have been a seller out there soaking up buys, but hopefully the positive turnaround means any overhang has now been cleared. |
Should see a little rally tomorrow. Once the IPOs start lining up it will be difficult to keep frontiers share price below the 85p nav. Remember, frontier was trading at a premium to nav a few years back. The current £23m market cap could be the valuation of just Pulsiv alone, forgetting the rest of the promising portfolio or cash |
Simon Thompson has a note out on them this afternoon
his colnclusion being -
Strip out pro-forma net cash of £4.4mn (7.8p) from Frontier’s market capitalisation of £23.9mn (42.5p) and investments worth £42.9mn (76.4p) are in the price for 55 per cent less than their carrying valuations despite offering potential for large gains on exit. The glaring disconnect between the value embedded in what is an exciting investment portfolio and the price attributed to the investments by the market is worth exploiting. Buy. |
Unfortunately I don’t think the market will give Frontier a reasonable valuation until hard cash starts flowing in through IPOs. If we believe this will happen we’re sitting on a bargain here - even if over half of the portfolio flop. |
Agree with your thoughts rivaldo. Alusid looks well on track for an IPO this year and worth noting that the Octopus fund that invested is a pre-IPO fund. Nandi, as alluded to by the CEO when we spoke, is very much making progress and looks like another that could deliver upside sooner than later. |
Results are out and look highly encouraging imo.
NAV has held up nicely at 84.2p given the macro environment. Cash is up to £4.4m including the final Exscientia shares sales.
Above all, a number of companies look particularly exciting - namely Alusid, CamGraPhIC, Fieldwork Robotics, Nandi Proteins, Pulsiv and The Vaccine Group.
A number of these are on the cusp of or are now selling product in quantity. Alusid is once again mentioned as IPO-ing soon. GraphEnergyTech and CamGraPhIC sound particularly exciting.
FIPP are trading at less than 50% of NAV. Much too great a discount. |
Nandi alive and kicking Finally positive update .Exciting update overall with several potential cash cows on the horizon |
www.astutegroup.com/news/industrial/groundbreaking-usb-c-technology-from-pulsiv-and-astute-electronics-signals-the-end-of-bulky-wall-chargers/ |
Pulsiv now in pre-launch for UBS C and marketing as such. |
Good catch up with the CEO yesterday and I plan to meet up with him after the Interim's in a couple of weeks time. So, I'll add my write up after that as there should be more to say then, as effectively in a closed period. For now, Nandi very much alive, but news dictated by commerciality agreements. A number of investments appear to be nearing key points, so there should be more on the news front through the year. Institutional sells down to a mix of change of fund managers and redemptions. Miton in particular has been selling a number of small cap stocks to meet redemptions, so FIPP isn't alone on that front. Happy to continue holding here as I believe the share price recent trend will reverse at some point, although I don't have my crystal ball to hand. |
Strong press release from Pulsiv today. |
Ask him in what order he expects the portfolio to reach ipo/trade sales? Nobody is likely to know the answer, but might lead to an interesting discussion |
Ask him in what order he expects the portfolio to reach ipo/trade sales? |
You could ask if Nandi proteins exist over 3 years since any comment news item on the website Remarkable |
I suspect it's down to redemptions in some cases, but it's on my list! |
Ask him why some institutions recently sold at such a positive stage |
Ask Neil if he will buy some FIPP shares please |
I have a call lined up with Neil Crabb tomorrow, so will add something following on from that. |
Cheers hastings, excellent write-up.
Pulsiv certainly looks extremely exciting - if it succeeds it will be worth a multiple of its current valuation, particularly if it attracts American institutional interest. Great to hear of those advanced orders as you say.
Here's an easier direct link: |
I didn't ask that, as I knew that it wouldn't be revealed! |
Did you dare to ask what they hope charge for the chip? I wouldn’t have expected an answer but just wondered if he had a ballpark figure. I just wondered if we’re looking at 2-3c or 10-20c or 50-75c. |
Pleased you found it of interest acuere.I think the fact they've already got advanced orders for the 65W USB-C modules in place ahead of the official launch along with the aim for significant volumes this year, bodes well. |
Cheers hastings.
I do feel they deserve to achieve success and i look forward to the news expected later this month.
Also pleased to see he not getting carried away by potential. I’m sure I’m not the only one to have crunched the numbers based on various percentages of target market, and concluded that Pulsiv, if it makes traction, will be worth a lot more than it’s current £50m. |
Write up for interest https://martinflitton1.wixsite.com/privatepunter/post/could-pulsiv-prove-to-be-a-tech-star-for-fipp-01-03-24 |
Register for streaming realtime charts, analysis tools, and prices.
Hot Features
Premium
